Category

Cohort News

Mobia Medical plans IPO

//
Categories
The neurostimulation device company intends to offer 10 million shares for between $14 and $16 each. Mobia said its Vivistim System, which received premarket approval in 2021, is the only approved solution for chronic ischemic stroke survivors with moderate to...
Read More →
1 2 3 159